More articles from Medical Grand Rounds
- Diabetes medications and cardiovascular outcome trials: Lessons learned
Drugs of several classes have demonstrated cardiovascular safety; empaglifl ozin carries a cardiovascular indication.
- Thrombotic microangiopathies: Similar presentations, different therapies
Effective management depends on prompt diagnosis and targeted therapy.
- Your patient has chronic leukemia: Now what?
New therapies for chronic myelogenous leukemia and chronic lymphocytic leukemia are increasing the number of survivors.
- Advances in the treatment of dyslipidemia
Current guidelines do not set specifi c targets for LDL-C, but evidence supports the concept that lower is better.
- 2015 Update on Parkinson disease
An improved understanding of the disease is leading to new diagnostic tools and treatments.
- Geriatrics update 2015: Vaccination, frailty, chronic disease guidelines, and cognition
Chronic disease-management guidelines are starting to recognize vulnerable elderly patients.
Dermatology update: The dawn of targeted treatmentNew, targeted therapies are changing the way advanced basal cell carcinoma, psoriasis, and metastatic melanoma are treated.
- The ‘skinny’ on eosinophilic esophagitis
Often starting in childhood, this disease progresses until the esophagus is visibly narrowed on radiography.
- Ebola virus: Questions, answers, and more questions
The clinical virology of Ebola virus, the reported proposed treatments, and an overview of the current outbreak.
